Get the Stockscreener App
1.73
1.76%
0.03
Vivos Therapeutics Inc stock is traded at $1.73, with a volume of 60,599.
It is up +1.76% in the last 24 hours and down -14.78% over the past month.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
See More
Previous Close:
$1.70
Open:
$1.7
24h Volume:
60,599
Relative Volume:
0.45
Market Cap:
$19.76M
Revenue:
$14.58M
Net Income/Loss:
$-12.57M
P/E Ratio:
-0.3046
EPS:
-5.68
Net Cash Flow:
$-13.07M
1W Performance:
-12.18%
1M Performance:
-14.78%
6M Performance:
-66.98%
1Y Performance:
-59.00%
1-Day Range:
$1.68
$1.74
1-Week Range:
$1.665
$2.01
52-Week Range:
$1.665
$7.95
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Name
Vivos Therapeutics Inc
Sector
Industry
Phone
(866)908-4867
Address
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
1.73 | 19.41M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
107.17 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.17 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.69 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.31 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.65 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Vivos Therapeutics Inc Stock (VVOS) Latest News
Chipmakers Recap: How does Vivos Therapeutics Inc score in quality rankingsEarnings Growth Summary & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.
Vivos Therapeutics Closes Exercise of 1.98M Warrants, Raising $4.64M - Intellectia AI
Vivos Therapeutics, Inc. Closes Exercise of Warrants Raising Approximately $4.64 Million for Working Capital - Quiver Quantitative
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds - The Manila Times
Sleep apnea device maker Vivos raises $4.64M in repriced warrant deal - Stock Titan
Vivos Therapeutics Completes Warrant Inducement Financing Transaction - TipRanks
Vivos Therapeutics Signs Warrant Inducement Agreement With Institutional Investor - TradingView
Chipmakers Recap: What is the dividend yield of Vivos Therapeutics IncAnalyst Upgrade & Low Risk High Reward Ideas - baoquankhu1.vn
Vivos Therapeutics (NASDAQ:VVOS) and Akebia Therapeutics (NASDAQ:AKBA) Head to Head Contrast - Defense World
Vivos Announces Warrant Exercise Agreement - Dentistry Today
Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds - MSN
Vivos Therapeutics announces $4.64 million warrant exercise deal By Investing.com - Investing.com Nigeria
Vivos Therapeutics Secures Convertible Bridge Financing Facility - TipRanks
Vivos Therapeutics Signs Convertible Note Agreement With V-Co Investors 3 - TradingView
Vivos Therapeutics announces $4.64 million warrant exercise deal - Investing.com India
Vivos Therapeutics (VVOS) Exercises Warrants for $4.64M in Funding - Intellectia AI
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds - The Manila Times
Sleep apnea device maker Vivos secures $4.64M from warrant exercise - Stock Titan
Dividend Watch: Is The Oncology Institute Inc Equity Warrants ROE strong enoughWeekly Earnings Recap & Weekly Momentum Picks - baoquankhu1.vn
Aug Summary: Is Vivos Therapeutics Inc part of any ETF2025 EndofYear Setup & Real-Time Volume Spike Alerts - baoquankhu1.vn
Earnings Risk: Will Allogene Therapeutics Inc stock hit new highs in YEARJobs Report & Weekly Market Pulse Alerts - baoquankhu1.vn
Alliance Global Partners Sticks to Its Hold Rating for Vivos Therapeutics (VVOS) - The Globe and Mail
Is Vivos Therapeutics Inc. stock a safe buy before earningsWeekly Stock Report & Long Hold Capital Preservation Tips - Улправда
Is Vivos Therapeutics Inc. stock a buy in volatile markets2025 Price Momentum & Weekly Stock Breakout Alerts - ulpravda.ru
Why analysts remain bullish on Vivos Therapeutics Inc. stockJuly 2025 Review & Safe Swing Trade Setup Alerts - Улправда
Can Vivos Therapeutics Inc. stock weather global recessionJuly 2025 Patterns & Growth Oriented Trade Recommendations - Улправда
Published on: 2026-01-08 23:11:17 - Улправда
Aug Update: Can Vivos Therapeutics Inc. stock weather global recessionPortfolio Profit Report & Fast Gaining Stock Reports - ulpravda.ru
Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga
How Vivos Therapeutics Inc. stock compares to industry benchmarksUtilities Sector Analysis & See Risk Factors Before Making Any Move - Улправда
Vivos Therapeutics (VVOS) upgraded to buy: Here's what you should know - MSN
Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know - sharewise.com
Is Vivos Therapeutics Inc a good long term investmentProtective Put Strategies & Ride the Trends That Billionaires Follow - earlytimes.in
Vivos Therapeutics (NASDAQ:VVOS) Trading Up 24.6% – What’s Next? - Defense World
Aug Breakouts: Why retail investors favor Vivos Therapeutics Inc stock2025 AllTime Highs & Capital Protection Trade Alerts - moha.gov.vn
VVOS SEC FilingsVivos Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Vivos Inc Summarizes Progress in its Animal Therapy Division - GlobeNewswire
Cancer-fighting pet therapy soars 1,200% as more vets join in 2025 - Stock Titan
A new cancer treatment for pets is quietly spreading across U.S. clinics - Stock Titan
Buyout Rumor: What dividend safety score for Vivos Therapeutics Inc. stockFed Meeting & Free Fast Entry Momentum Trade Alerts - Улправда
Will Vivos Therapeutics Inc. stock see insider buyingRecession Risk & Safe Capital Growth Trade Ideas - Улправда
ETF Watch: What dividend safety score for Vivos Therapeutics Inc. stockJuly 2025 Macro Moves & Fast Gaining Stock Strategy Reports - Улправда
Is Vivos Therapeutics Inc. stock a safe investment in uncertain marketsPortfolio Risk Summary & Low Risk Investment Opportunities - DonanımHaber
Why Vivos Therapeutics Inc. stock is popular among millennialsWeekly Profit Summary & Stepwise Trade Signal Guides - Bölüm Sonu Canavarı
Published on: 2025-12-19 13:18:12 - DonanımHaber
Stop Loss: How Vivos Therapeutics Inc. stock compares to industry benchmarksAnalyst Upgrade & Free Weekly Chart Analysis and Trade Guides - Улправда
Vivos Therapeutics Opens Affiliated Sleep Center in Michigan - Sleep Review
Vivos Therapeutics, Inc. Announces Grand Opening of Sleep Center in Michigan - TradingView — Track All Markets
Vivos opens new sleep center in Michigan, expanding national footprint By Investing.com - Investing.com Nigeria
Vivos opens new sleep center in Michigan, expanding national footprint - Investing.com India
Vivos Therapeutics Inc Stock (VVOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.90%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):